苏泊尔(002032) - 2025 Q3 - 季度财报

Financial Performance - Q3 2025 revenue was CNY 5,419,756,325.97, a decrease of 2.30% year-over-year, while year-to-date revenue reached CNY 16,897,257,126.38, an increase of 2.33%[5] - Net profit attributable to shareholders for Q3 2025 was CNY 426,221,896.85, down 13.42% year-over-year, and year-to-date net profit was CNY 1,366,135,690.98, a decrease of 4.66%[5] - Basic earnings per share for Q3 2025 was CNY 0.535, reflecting a decline of 13.43% compared to the same period last year[5] - Net profit for the current period is approximately ¥1.36 billion, a decrease from ¥1.43 billion in the previous period, representing a decline of about 4.8%[22] - Operating profit for the current period is approximately ¥1.70 billion, compared to ¥1.78 billion in the previous period, reflecting a decrease of about 4.6%[22] - The company reported a total comprehensive income of approximately ¥1.34 billion, down from ¥1.43 billion in the previous period, indicating a decrease of about 5.5%[22] - Basic earnings per share for the current period is ¥1.715, a decrease from ¥1.798 in the previous period, representing a decline of about 4.6%[22] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 12,636,292,260.01, a decrease of 4.75% from the end of the previous year[5] - Total assets decreased to ¥12,636,292,260.01 from ¥13,265,856,724.52, a decline of 4.76%[17] - Total liabilities increased to ¥7,062,440,071.13 from ¥6,804,329,401.24, reflecting an increase of 3.79%[18] - The company's equity attributable to shareholders decreased to ¥5,539,767,154.18 from ¥6,424,414,343.69, a drop of 13.76%[18] Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 1,352,363,553.80, an increase of 16.57%[5] - Cash flow from operating activities net amount is approximately ¥1.35 billion, up from ¥1.16 billion in the previous period, indicating an increase of about 16.5%[24] - The company's cash and cash equivalents decreased to ¥1,765,561,626.67 from ¥2,480,007,318.69, a decline of 28.87%[16] - Cash and cash equivalents at the end of the period are approximately ¥1.29 billion, down from ¥2.23 billion at the end of the previous period, indicating a decrease of about 42.1%[24] Investment and Expenses - Investment income increased by 73.92% year-over-year, attributed to higher investments in transferable large-denomination certificates of deposit[13] - Financial expenses rose by 61.37% year-over-year, primarily due to a decrease in interest income[9] - Net cash flow from investing activities decreased by 93.19% year-over-year, mainly due to increased cash outflows for investment activities[10] - Research and development expenses for the current period are approximately ¥337.11 million, slightly up from ¥327.39 million in the previous period, marking an increase of about 2.2%[22] - Sales expenses for the current period are approximately ¥1.72 billion, compared to ¥1.56 billion in the previous period, reflecting an increase of about 9.8%[22] - The company recorded investment income of approximately ¥38.46 million, an increase from ¥22.12 million in the previous period, reflecting a growth of about 74.1%[22] Operational Metrics - Total operating revenue for the period reached ¥16,897,257,126.38, an increase of 2.33% compared to ¥16,512,360,853.44 in the previous period[20] - Total operating costs amounted to ¥15,308,058,574.28, up from ¥14,813,697,932.05, reflecting a year-over-year increase of 3.34%[20] - Accounts receivable rose to ¥3,132,702,483.68, compared to ¥2,690,049,028.80, indicating an increase of 16.43%[16] - Inventory levels decreased to ¥2,008,697,303.58 from ¥2,565,958,108.47, a reduction of 21.73%[16] Future Outlook - Future outlook includes potential market expansion and new product development strategies, although specific figures were not disclosed[19]